Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

- PMLiVE

Aurora named Communiqué Communications Consultancy of the Year

Builds on last year's success to triumph at 2013 Communiqué Awards

Maximising patient adherence by leveraging the patient/ physician/ pharma relationship

Director Marc Yates looks at the problem of patient compliance - can a better understanding of patient attitudes, needs and behaviours help pharma develop strategies to improve adherence?

Inizio

Digital research in Asia

Director Marc Yates uses findings from a study conducted in six markets in Asia to explore how digital channels are being utilised by consumers and look at the digital opportunities...

Inizio

Achieving customer centricity – Using immersion techniques to get closer to the pulse of the customer

Director Marc Yates discusses the importance of being customer-centric in the pharmaceutical industry and how immersion techniques in market research can help develop a better understanding of the customer.

Inizio

The Mobile Revolution – Using mobile Apps to deliver “in-the-moment” market research to global healthcare

Director John Branston investigates the use of mobile research in order to capture immediate detailed, qualitative insights into prescription rationale at the patient level.

Inizio

Biopharma looks to social media to assist patient recruitment in trials

Canadian company Qu Biologics hopes Twitter and Facebook will help its Crohn's study

- PMLiVE

Medicare puts brake on Lilly’s Alzheimer’s test

Will only reimburse new Alzheimer's diagnostic Amyvid for patients in trials

- PMLiVE

Pharma facing EU challenge over promotional products ban

Manufacturers of USB sticks, sticky notes and pens complain to the European Commission

Croatia joins European medicines network

Follows country's membership of the European Union

- PMLiVE

Warp Drive Bio names Gregory Verdine as CEO

Joined by James Nichols as chief operating officer and new board member Julian Adams

- PMLiVE

FDA grants orphan status to Activartis’ brain cancer immunotherapy

Regulator says AV0113 has potential in rare cancer malignant glioma

- PMLiVE

A tailored approach to the BRIC markets

Patience, long-term thinking and strategies that are tailored to each market are key to pharma success in the BRIC countries and other emerging markets

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links